Accendra Health, Inc.

As of June 30, 2026, Accendra Health Inc carries a market capitalization of 230.71M, placing it among publicly traded companies globally. Its enterprise value stands at 1.78B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Accendra Health Inc's next confirmed earnings release is scheduled for November 4, 2026.

As of June 30, 2026, Accendra Health Inc has 76.90M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.10, and the price-to-book ratio stands at -0.48.

As of June 30, 2026, Accendra Health Inc trades at an EV/EBITDA multiple of 7.14 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.77 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 69.40 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 1.78B versus a market cap of 230.71M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Accendra Health Inc maintains a current ratio of 0.41, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -323.32, indicating conservative leverage, while an interest coverage ratio of 2.30 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -9.65, reflecting losses generated across the asset base. The company generates approximately 217,061.69 in revenue per employee across its workforce of 10,675.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 20.49 indicates how many times Accendra Health Inc sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Accendra Health Inc recorded an income tax benefit of -4.28M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -101.08M and -264.46M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Accendra Health Inc's stock has declined approximately 96.00% over the past 52 weeks. The 50-day moving average sits at 0.71, while the 200-day moving average is 1.99.

Over the twelve months ended June 30, 2026, Accendra Health Inc generated 2.32B in revenue and converted that into -264.46M in net income, yielding earnings per share of -1.26. EBITDA reached 249.84M, while operating income came in at 131.97M.

As of June 30, 2026, Accendra Health Inc holds 6.70M in cash and equivalents against 1.56B in total debt, resulting in a net debt position of 1.50B. Total book value stands at -482.24M, with working capital of -345.54M providing operational flexibility.

Accendra Health Inc produced -157.92M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -162.08M in capital expenditures, free cash flow totaled -320.00M - equivalent to -4.17 per share.

Over the twelve months ended June 30, 2026, Accendra Health Inc posted a gross margin of 44.83, reflecting its pricing power and cost economics. The operating margin of 5.70 and net profit margin of -11.41 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -138.93: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 59.67, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Accendra Health Inc shareholders.

Accendra Health Inc's most recent stock split took place on April 1, 2010 with a 2:3 split ratio.

As of June 30, 2026, Accendra Health Inc has an Altman Z-Score of 1.34, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.